J Gynecol Oncol.  2019 Nov;30(6):e116. 10.3802/jgo.2019.30.e116.

Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?

Affiliations
  • 1Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Fudan University Zhongshan Hospital, Shanghai, China. zang.rongyu@zs-hospital.sh.cn
  • 2Department of Gynecologic Oncology, University Cancer Hospital of Chinese Science Academy, Hangzhou, China.

Abstract

No abstract available.


MeSH Terms

Humans
Ovarian Neoplasms*
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr